This response was submitted to the Star Tribune on 1/26. It's unclear if it will be published so we are posting it here too.
The January 22 editorial “It's up to Congress to curb the high costs of prescription drugs” is spot on. It’s time Congress moves “beyond political theater" on this issue. House Democrats … Continue to Article-->
Martin Skhreli, the hedge fund manager turned pharma executive who is infamous for raising a drug’s price 5000 percent overnight, is now refusing to cooperate with two Congressional inquiries into drug prices.
Turing Pharmaceuticals CEO Skhreli invoked the Fifth Amendment and refused to provide documents related to … Continue to Article-->
By Ezekiel J. Emanuel, M.D., Ph.D.
What's the least controversial statement anyone could make about health care costs in the United States?
Drug prices are out of control.
No one really disputes it, and the real question is, Do we have the political will to do anything about it?
A classic case … Continue to Article-->
More than 50 members of Congress are urging the Department of Health and Human Services (HHS) and National Institutes of Health (NIH) to use their authority to bring relief to consumers struggling to pay exorbitant drug prices.
A letter to Secretary of HHS Burwell and NIH Director Collins requests the development of … Continue to Article-->
RxRights has been working to promote and protect your access to affordable medicine for more than 5 years. Each year, we review our progress, reflect back on lessons learned, and look forward to the future.
We have long warned that unaffordable drug prices amount to a public health crisis in America. Up until this past … Continue to Article-->